152 related articles for article (PubMed ID: 28481918)
41. SNP association mapping across the extended major histocompatibility complex and risk of B-cell precursor acute lymphoblastic leukemia in children.
Urayama KY; Chokkalingam AP; Metayer C; Hansen H; May S; Ramsay P; Wiemels JL; Wiencke JK; Trachtenberg E; Thompson P; Ishida Y; Brennan P; Jolly KW; Termuhlen AM; Taylor M; Barcellos LF; Buffler PA
PLoS One; 2013; 8(8):e72557. PubMed ID: 23991122
[TBL] [Abstract][Full Text] [Related]
42. High-resolution melting analyses for genetic variants in ARID5B and IKZF1 with childhood acute lymphoblastic leukemia susceptibility loci in Taiwan.
Lin CY; Li MJ; Chang JG; Liu SC; Weng T; Wu KH; Yang SF; Huang FK; Lo WY; Peng CT
Blood Cells Mol Dis; 2014; 52(2-3):140-5. PubMed ID: 24200646
[TBL] [Abstract][Full Text] [Related]
43. [Methylation of the genes in the 9P21 region in children with acute myeloid leukemia].
Zhang L; Ruan M; Liu XM; Zhang JY; Guo Y; Yang WY; Liu F; Liu TF; Wang SC; Chen XJ; Zou Y; Chen YM; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jan; 17(1):6-10. PubMed ID: 25616284
[TBL] [Abstract][Full Text] [Related]
44. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
[TBL] [Abstract][Full Text] [Related]
45. Islet biology, the CDKN2A/B locus and type 2 diabetes risk.
Kong Y; Sharma RB; Nwosu BU; Alonso LC
Diabetologia; 2016 Aug; 59(8):1579-93. PubMed ID: 27155872
[TBL] [Abstract][Full Text] [Related]
46. A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution.
Walsh KM; de Smith AJ; Hansen HM; Smirnov IV; Gonseth S; Endicott AA; Xiao J; Rice T; Fu CH; McCoy LS; Lachance DH; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR; Ma X; Metayer C; Wiemels JL
Cancer Res; 2015 Nov; 75(22):4884-94. PubMed ID: 26527286
[TBL] [Abstract][Full Text] [Related]
47. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma.
Iolascon A; Giordani L; Moretti A; Basso G; Borriello A; Della Ragione F
Hepatology; 1998 Apr; 27(4):989-95. PubMed ID: 9537438
[TBL] [Abstract][Full Text] [Related]
48. Association of CDKN2A/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children.
Ruan Y; Xie L; Zou A
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10841-10850. PubMed ID: 37314514
[TBL] [Abstract][Full Text] [Related]
49. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
50. Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.
Brown AL; de Smith AJ; Gant VU; Yang W; Scheurer ME; Walsh KM; Chernus JM; Kallsen NA; Peyton SA; Davies GE; Ehli EA; Winick N; Heerema NA; Carroll AJ; Borowitz MJ; Wood BL; Carroll WL; Raetz EA; Feingold E; Devidas M; Barcellos LF; Hansen HM; Morimoto L; Kang AY; Smirnov I; Healy J; Laverdière C; Sinnett D; Taub JW; Birch JM; Thompson P; Spector LG; Pombo-de-Oliveira MS; DeWan AT; Mullighan CG; Hunger SP; Pui CH; Loh ML; Zwick ME; Metayer C; Ma X; Mueller BA; Sherman SL; Wiemels JL; Relling MV; Yang JJ; Lupo PJ; Rabin KR
Blood; 2019 Oct; 134(15):1227-1237. PubMed ID: 31350265
[TBL] [Abstract][Full Text] [Related]
51. A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer.
ShahidSales S; Mehramiz M; Ghasemi F; Aledavood A; Shamsi M; Hassanian SM; Ghayour-Mobarhan M; Avan A
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28276595
[TBL] [Abstract][Full Text] [Related]
52. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
[TBL] [Abstract][Full Text] [Related]
53. The functional role of inherited CDKN2A variants in childhood acute lymphoblastic leukemia.
Li C; Zhao X; He Y; Li Z; Qian J; Zhang L; Ye Q; Qiu F; Lian P; Qian M; Zhang H
Pharmacogenet Genomics; 2022 Feb; 32(2):43-50. PubMed ID: 34369425
[TBL] [Abstract][Full Text] [Related]
54. Variants of CDKAL1 rs7754840 (G/C) and CDKN2A/2B rs10811661 (C/T) with gestational diabetes: insignificant association.
Noury AE; Azmy O; Alsharnoubi J; Salama S; Okasha A; Gouda W
BMC Res Notes; 2018 Mar; 11(1):181. PubMed ID: 29544538
[TBL] [Abstract][Full Text] [Related]
55. Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors.
Campa D; Capurso G; Pastore M; Talar-Wojnarowska R; Milanetto AC; Landoni L; Maiello E; Lawlor RT; Malecka-Panas E; Funel N; Gazouli M; De Bonis A; Klüter H; Rinzivillo M; Delle Fave G; Hackert T; Landi S; Bugert P; Bambi F; Archibugi L; Scarpa A; Katzke V; Dervenis C; Liço V; Furlanello S; Strobel O; Tavano F; Basso D; Kaaks R; Pasquali C; Gentiluomo M; Rizzato C; Canzian F
Sci Rep; 2016 Dec; 6():39565. PubMed ID: 28008994
[TBL] [Abstract][Full Text] [Related]
56. Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia.
Braun M; Pastorczak A; Fendler W; Madzio J; Tomasik B; Taha J; Bielska M; Sedek L; Szczepanski T; Matysiak M; Derwich K; Lejman M; Kowalczyk J; Kazanowska B; Badowska W; Styczynski J; Irga-Jaworska N; Trelinska J; Zalewska-Szewczyk B; Pierlejewski F; Wlodarska I; Młynarski W;
Leuk Lymphoma; 2017 May; 58(5):1162-1171. PubMed ID: 27756164
[TBL] [Abstract][Full Text] [Related]
57. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
58. Association of CDKAL1, CDKN2A/B & HHEX gene polymorphisms with type 2 diabetes mellitus in the population of Hyderabad, India.
Kommoju UJ; Samy SK; Maruda J; Irgam K; Kotla JP; Velaga L; Reddy BM
Indian J Med Res; 2016 Apr; 143(4):455-63. PubMed ID: 27377502
[TBL] [Abstract][Full Text] [Related]
59. Association Study Between Coronary Artery Disease and rs1333049 Polymorphism at 9p21.3 Locus in Italian Population.
Pignataro P; Pezone L; Di Gioia G; Franco D; Iaccarino G; Iolascon A; Ciccarelli M; Capasso M
J Cardiovasc Transl Res; 2017 Dec; 10(5-6):455-458. PubMed ID: 28639227
[TBL] [Abstract][Full Text] [Related]
60. Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment.
Gutierrez-Camino Á; Umerez M; Lopez-Lopez E; Santos-Zorrozua B; Martin-Guerrero I; de Andoin NG; Ana S; Navajas A; Astigarraga I; Garcia-Orad A
Pharmacogenomics; 2018 Dec; 19(18):1403-1412. PubMed ID: 30479191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
